FineMark National Bank & Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$12.7M Sell
121,064
-2,302
-2% -$216K 0.4% 65
2025
Q3
$10.4M Sell
123,366
-3,915
-3% -$322K 0.34% 81
2025
Q2
$10.1M Buy
127,281
+770
+0.6% +$61.2K 0.34% 78
2025
Q1
$11.4M Sell
126,511
-1,439
-1% -$134K 0.41% 73
2024
Q4
$12.7M Sell
127,950
-2,837
-2% -$292K 0.44% 63
2024
Q3
$14.9M Sell
130,787
-1,165
-0.9% -$138K 0.52% 58
2024
Q2
$16.3M Sell
131,952
-1,076
-0.8% -$139K 0.6% 46
2024
Q1
$17.6M Buy
133,028
+1,888
+1% +$233K 0.65% 34
2023
Q4
$14.3M Sell
131,140
-2,109
-2% -$219K 0.58% 41
2023
Q3
$13.7M Sell
133,249
-4,759
-3% -$513K 0.6% 41
2023
Q2
$15.9M Sell
138,008
-3,870
-3% -$439K 0.65% 37
2023
Q1
$15.1M Sell
141,878
-12,908
-8% -$1.39M 0.64% 39
2022
Q4
$17.2M Sell
154,786
-7,570
-5% -$774K 0.77% 31
2022
Q3
$14M Sell
162,356
-656
-0.4% -$58.6K 0.67% 34
2022
Q2
$14.9M Buy
163,012
+1,319
+0.8% +$117K 0.66% 35
2022
Q1
$13.3M Sell
161,693
-2,139
-1% -$169K 0.52% 43
2021
Q4
$12.6M Sell
163,832
-4,728
-3% -$377K 0.48% 49
2021
Q3
$12.7M Sell
168,560
-176
-0.1% -$13.4K 0.54% 45
2021
Q2
$13.1M Sell
168,736
-9,475
-5% -$705K 0.53% 44
2021
Q1
$13.1M Sell
178,211
-55,079
-24% -$4.06M 0.55% 42
2020
Q4
$18.2M Sell
233,290
-4,776
-2% -$365K 0.81% 22
2020
Q3
$18.8M Sell
238,066
-340
-0.1% -$26.6K 0.91% 20
2020
Q2
$17.6M Buy
238,406
+478
+0.2% +$36K 0.97% 19
2020
Q1
$17.5M Buy
237,928
+6,638
+3% +$522K 1.1% 14
2019
Q4
$20.1M Buy
231,290
+4,792
+2% +$394K 1% 16
2019
Q3
$18.2M Buy
226,498
+5,952
+3% +$477K 0.97% 18
2019
Q2
$17.6M Buy
220,546
+7,241
+3% +$554K 0.98% 17
2019
Q1
$16.9M Sell
213,305
-735
-0.3% -$55K 0.98% 17
2018
Q4
$15.6M Buy
214,040
+5,566
+3% +$393K 1.06% 13
2018
Q3
$14.1M Sell
208,474
-13,061
-6% -$832K 0.86% 22
2018
Q2
$12.8M Buy
221,535
+4,985
+2% +$281K 0.78% 26
2018
Q1
$11.3M Sell
216,550
-13
-0% -$702 0.72% 32
2017
Q4
$11.6M Sell
216,563
-9,667
-4% -$536K 0.74% 30
2017
Q3
$13.8M Buy
226,230
+40,973
+22% +$2.48M 0.92% 17
2017
Q2
$11.3M Buy
185,257
+1,166
+0.6% +$71K 0.81% 24
2017
Q1
$11.2M Buy
184,091
+8,236
+5% +$500K 0.82% 24
2016
Q4
$9.88M Buy
175,855
+4,697
+3% +$275K 0.79% 26
2016
Q3
$10M Sell
171,158
-25,214
-13% -$1.47M 1.07% 22
2016
Q2
$10.8M Buy
196,372
+8,932
+5% +$475K 1.2% 16
2016
Q1
$9.46M Buy
187,440
+9,698
+5% +$475K 1.11% 23
2015
Q4
$8.96M Buy
177,742
+23,501
+15% +$1.18M 1.07% 18
2015
Q3
$7.27M Buy
154,241
+22,096
+17% +$1.17M 0.98% 24
2015
Q2
$7.18M Buy
132,145
+36,983
+39% +$2.07M 0.94% 20
2015
Q1
$5.22M Buy
95,162
+18,769
+25% +$1.06M 0.71% 34
2014
Q4
$4.14M Buy
76,393
+927
+1% +$51.6K 0.61% 40
2014
Q3
$4.27M Sell
75,466
-2,591
-3% -$145K 0.68% 37
2014
Q2
$4.31M Buy
78,057
+2,166
+3% +$118K 0.73% 33
2014
Q1
$4.11M Sell
75,891
-2,361
-3% -$122K 0.77% 29
2013
Q4
$3.74M Sell
78,252
-5,932
-7% -$271K 0.77% 27
2013
Q3
$3.82M Buy
84,184
+20,645
+32% +$943K 0.95% 21
2013
Q2
$2.84M Buy
+63,539
New +$2.84M 0.85% 25

Other funds holding MRK

FineMark National Bank & Trust's MRK Position: Q4 2025 in Review

FineMark National Bank & Trust reduced its Merck (MRK) stake by 1.9% in Q4 2025, selling an estimated $216K and leaving 121,064 shares worth $12.7M. The position accounts for 0.4% of the portfolio, ranked #65.

FineMark National Bank & Trust first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $20.1M in Q4 2019. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • FineMark National Bank & Trust held 121,064 shares of Merck worth $12.7M as of Q4 2025.
  • FineMark National Bank & Trust sold 2,302 Merck shares in Q4 2025, an estimated $216K.
  • Merck made up 0.4% of FineMark National Bank & Trust's portfolio in Q4 2025, its #65 holding.
  • FineMark National Bank & Trust first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • FineMark National Bank & Trust's Merck position peaked at $20.1M in Q4 2019.
  • 3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.